84
Views
6
CrossRef citations to date
0
Altmetric
Case Series

The use of autologous serum for the treatment of ocular surface disease at a Swedish tertiary referral center

, &
Pages 47-54 | Published online: 02 Mar 2016

References

  • LambiaseAManniLBoniniSRamaPMiceraAAloeLNerve growth factor promotes corneal healing: structural, biochemical, and molecular analyses of rat and human corneasInvest Ophthalmol Vis Sci20004151063106910752942
  • LambiaseARamaPBoniniSCaprioglioGAloeLTopical treatment with nerve growth factor for corneal neurotrophic ulcersN Engl J Med199833817117411809554857
  • McClintockJLCeresaBPTransforming growth factor-{alpha} enhances corneal epithelial cell migration by promoting EGFR recyclingInvest Ophthalmol Vis Sci20105173455346120181835
  • OhashiYMotokuraMKinoshitaYPresence of epidermal growth factor in human tearsInvest Ophthalmol Vis Sci1989308187918822788149
  • UbelsJLFoleyKMRismondoVRetinol secretion by the lacrimal glandInvest Ophthalmol Vis Sci1986278126112683733370
  • WilsonSELiangQKimWJLacrimal gland HGF, KGF, and EGF mRNA levels increase after corneal epithelial woundingInvest Ophthalmol Vis Sci199940102185219010476782
  • NishidaTOhashiYAwataTManabeRFibronectin. A new therapy for corneal trophic ulcerArch Ophthalmol19831017104610486870626
  • GeerlingGMaclennanSHartwigDAutologous serum eye drops for ocular surface disordersBr J Ophthalmol200488111467147415489495
  • TsubotaKGotoEFujitaHTreatment of dry eye by autologous serum application in Sjogren’s syndromeBr J Ophthalmol199983439039510434857
  • RalphRADoaneMGDohlmanCHClinical experience with a mobile ocular perfusion pumpArch Ophthalmol19759310103910431180750
  • FoxRIChanRMichelsonJBBelmontJBMichelsonPEBeneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis siccaArthritis Rheum19842744594616712760
  • JengBHUse of autologous serum in the treatment of ocular surface disordersArch Ophthalmol2011129121610161222159683
  • ChoiJAChungSHCombined application of autologous serum eye drops and silicone hydrogel lenses for the treatment of persistent epithelial defectsEye Contact Lens201137637037321983552
  • OgawaYOkamotoSMoriTAutologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host diseaseBone Marrow Transplant200331757958312692625
  • KojimaTIshidaRDogruMThe effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control studyAm J Ophthalmol2005139224224615733983
  • NobleBALohRSMacLennanSComparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface diseaseBr J Ophthalmol200488564765215090417
  • PoonACGeerlingGDartJKFraenkelGEDanielsJTAutologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studiesBr J Ophthalmol200185101188119711567963
  • TananuvatNDaniellMSullivanLJControlled study of the use of autologous serum in dry eye patientsCornea200120880280611685055
  • TsubotaKGotoEShimmuraSShimazakiJTreatment of persistent corneal epithelial defect by autologous serum applicationOphthalmology1999106101984198910519596
  • JengBHDuppsWJJrAutologous serum 50% eyedrops in the treatment of persistent corneal epithelial defectsCornea200928101104110819730088
  • PanQAngelinaAZambranoAAutologous serum eye drops for dry eyeCochrane Database Syst Rev20138CD00932723982997
  • LawrenceDATransforming growth factor-beta: a general reviewEur Cytokine Netw1996733633748954178
  • ChoYKHuangWKimGYLimBSComparison of autologous serum eye drops with different diluentsCurr Eye Res201338191722928476
  • LagnadoRKingAJDonaldFDuaHSA protocol for low contamination risk of autologous serum drops in the management of ocular surface disordersBr J Ophthalmol200488446446515031155
  • VersuraPProfazioVBuzziMEfficacy of standardized and quality-controlled cord blood serum eye drop therapy in the healing of severe corneal epithelial damage in dry eyeCornea201332441241822955120
  • BradleyJCSimoniJBradleyRHMcCartneyDLBrownSMTime-and temperature-dependent stability of growth factor peptides in human autologous serum eye dropsCornea200928220020519158565
  • FischerKROpitzABoeckMGeerlingGStability of serum eye drops after storage of 6 monthsCornea201231111313131822955119
  • RochaEMPelegrinoFSde PaivaCSVigoritoACde SouzaCAGVHD dry eyes treated with autologous serum tearsBone Marrow Transplant200025101101110310828873
  • McDonnellPJSchanzlinDJRaoNAImmunoglobulin deposition in the cornea after application of autologous serumArch Ophthalmol198810610142314253052385
  • ButrusSILeungDYGellisSBaumJKenyonKRAbelsonMBVernal conjunctivitis in the hyperimmunoglobulinemia E syndromeOphthalmology19849110121312166240007
  • VersuraPBuzziMGiannaccareGTargeting growth factor supply in keratopathy treatment: comparison between maternal peripheral blood and cord blood as sources for the preparation of topical eye dropsBlood Transfus Epub201579
  • Lopez-GarciaJSRivasLGarcia-LozanoIMurubeJAutologous serum eyedrops in the treatment of aniridic keratopathyOphthalmology2008115226226717675158
  • MatsumotoYDogruMGotoEAutologous serum application in the treatment of neurotrophic keratopathyOphthalmology200411161115112015177961
  • JooMJYuhanKRHyonJYThe effect of nerve growth factor on corneal sensitivity after laser in situ keratomileusisArch Ophthalmol200412291338134115364713